BSE Live
Mar 09, 16:01Prev. Close
751.25
Open Price
731.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 09, 15:59Prev. Close
751.25
Open Price
720.05
Bid Price (Qty.)
741.00 (1195)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Senores Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
| Per Share Ratios | |||||
| Basic EPS (Rs.) | 16.12 | 13.67 | 8.87 | 1.81 | |
| Diluted EPS (Rs.) | 16.12 | 12.21 | 6.65 | 1.81 | |
| Cash EPS (Rs.) | 16.33 | 14.01 | 10.40 | 1.94 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 170.73 | 66.96 | 46.36 | 41.86 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 170.73 | 66.96 | 46.36 | 41.86 | |
| Revenue from Operations/Share (Rs.) | 86.48 | 70.32 | 36.00 | 16.21 | |
| PBDIT/Share (Rs.) | 23.66 | 14.56 | 16.66 | 2.76 | |
| PBIT/Share (Rs.) | 20.00 | 11.27 | 14.85 | 1.95 | |
| PBT/Share (Rs.) | 15.32 | 8.18 | 12.67 | 1.31 | |
| Net Profit/Share (Rs.) | 12.67 | 10.72 | 8.59 | 1.13 | |
| NP After MI And SOA / Share (Rs.) | 12.72 | 10.31 | 8.59 | 1.13 | |
| Profitability Ratios | |||||
| PBDIT Margin (%) | 27.35 | 20.70 | 46.28 | 17.02 | |
| PBIT Margin (%) | 23.13 | 16.03 | 41.24 | 12.05 | |
| PBT Margin (%) | 17.72 | 11.62 | 35.19 | 8.06 | |
| Net Profit Margin (%) | 14.64 | 15.24 | 23.86 | 6.99 | |
| NP After MI And SOA Margin (%) | 14.70 | 14.66 | 23.86 | 6.99 | |
| Return on Networth/Equity (%) | 7.44 | 15.39 | 18.53 | 2.70 | |
| Return on Capital Employed (%) | 9.34 | 9.18 | 18.40 | 3.46 | |
| Return on Assets (%) | 4.77 | 5.05 | 6.43 | 1.67 | |
| Total Debt/Equity (X) | 0.39 | 1.22 | 1.34 | 0.39 | |
| Asset Turnover Ratio (%) | 0.43 | 0.57 | 0.37 | 0.00 | |
| Liquidity Ratios | |||||
| Current Ratio (X) | 3.00 | 1.01 | 0.99 | 2.74 | |
| Quick Ratio (X) | 2.77 | 0.86 | 0.93 | 2.43 | |
| Inventory Turnover Ratio (X) | 8.47 | 10.59 | 0.11 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Coverage Ratios | |||||
| Interest Coverage Ratios (%) | 5.06 | 4.70 | 7.65 | 4.27 | |
| Interest Coverage Ratios (Post Tax) (%) | 5.06 | 4.70 | 7.65 | 4.27 | |
| Valuation Ratios | |||||
| Enterprise Value (Cr.) | 2,582.83 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 6.49 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 23.70 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 6.62 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 3.35 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 6.62 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.02 | 0.00 | 0.00 | 0.00 |
21.01.2026
Senores Pharma Standalone December 2025 Net Sales at Rs 28.76 crore, up 199.9% Y-o-Y
16.12.2025
12.11.2025
Senores Pharma Standalone September 2025 Net Sales at Rs 35.33 crore, up 266.87% Y-o-Y
07.11.2025
Senores Pharma Consolidated September 2025 Net Sales at Rs 161.76 crore, down 10.24% Y-o-Y
21.01.2026
Senores Pharma Standalone December 2025 Net Sales at Rs 28.76 crore, up 199.9% Y-o-Y
12.11.2025
Senores Pharma Standalone September 2025 Net Sales at Rs 35.33 crore, up 266.87% Y-o-Y
07.11.2025
Senores Pharma Consolidated September 2025 Net Sales at Rs 161.76 crore, down 10.24% Y-o-Y
24.07.2025
Senores Pharma Standalone June 2025 Net Sales at Rs 19.82 crore, up 164.97% Y-o-Y